Written Question·Department of Health and Social Care·UIN 32904

Mefloquine: Side Effects

Tabled: 24 February 2025

Answered: 27 February 2025

Named Day

Question

Sir Julian Lewis

To ask the Secretary of State for Health and Social Care, what guidance his Department gives to medical practitioners on the (a) risks of harmful long-term effects resulting from the prescription of Lariam (Mefloquine) as an anti-malarial prophylaxis and

Answer

Karin Smyth

Mefloquine, commercially known as Lariam, is effective in the prevention and treatment of malaria and is licensed for use by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. The current product information for mefloqui...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 32904) →